Hub : Traits :

Guilty feelings

168 significantly associated models · 34 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 2 22911727 24924438 2 2 7.1e-14 3.5e-13 1.0e+00 100 KLHL29 UBXN2A
2 2 97351840 98736225 1 1 1.9e-07 1.4e-02 2.4e-01 77 IGKV2OR2-8
3 3 80855269 82499607 1 1 2.5e-07 3.4e-07 8.5e-02 89 GBE1
4 5 139242290 140571526 1 1 2.7e-07 1.3e-05 7.9e-02 84 APBB3
5 6 104706579 106230491 1 1 1.2e-07 1.8e-07 2.1e-01 94 LIN28B
6 8 8092025 8794801 2 1 5.2e-08 3.3e-07 1.2e-01 91 FAM86B3P
7 8 10265712 11891593 4 1 8.9e-09 1.4e-07 1.9e-01 94 AF131215.2
8 11 46917983 48303325 1 1 1.6e-07 1.1e-07 1.9e-01 94 C1QTNF4
9 11 56742853 58178587 2 1 5.3e-09 1.3e-07 1.9e-01 94 MED19
10 11 112135760 113969669 4 2 3.0e-09 2.4e-09 1.8e-05 48 ANKK1 NCAM1
11 14 74424938 76089054 4 1 1.8e-09 2.9e-09 3.6e-03 76 AREL1
12 15 77207277 78806023 1 1 1.6e-07 2.0e-07 1.0e+00 100 LINGO1
13 17 42774693 43913030 7 1 9.3e-09 1.8e-07 8.4e-02 89 PLEKHM1
14 22 39229593 40615276 1 1 1.0e-07 2.8e-07 3.3e-01 96 ATF4

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Alzheimer’s Disease (including proxy) 1.99 1 0 0.0 0.00 1.0e+00 C1QTNF4
Major Depression (MDD) 3.23 1 0 0.0 0.00 1.0e+00 AREL1
Reaction Time 1.51 1 0 0.0 0.00 1.0e+00 GBE1
Verbal and Numeric Reasoning (VNR) 3.74 4 1 3.0 0.31 6.9e-01 APBB3 ATF4 NCAM1 PLEKHM1
Breast Cancer 1.28 1 1 3.0 0.00 1.0e+00 PLEKHM1
Ovarian Cancer 2.85 1 1 3.0 0.00 1.0e+00 PLEKHM1
Age at First Birth 4.26 1 1 3.0 0.00 1.0e+00 IGKV2OR2-8
Body Mass Index (BMI) (2010) 3.37 1 1 3.0 0.00 1.0e+00 C1QTNF4
Fasting Glucose 1.68 1 0 0.0 0.00 1.0e+00 C1QTNF4
HDL Cholesterol 1.45 1 0 0.0 0.00 1.0e+00 IGKV2OR2-8
Lupus 2.78 2 0 0.0 0.00 1.0e+00 AF131215.2 FAM86B3P
Neuroticism 11.32 7 4 12.1 -0.97 3.6e-04 AF131215.2 ANKK1 AREL1 C1QTNF4 FAM86B3P LINGO1 PLEKHM1
Primary Biliary Cirrhosis 1.70 1 0 0.0 0.00 1.0e+00 PLEKHM1
Schizophrenia 3.40 3 0 0.0 0.00 1.0e+00 AREL1 FAM86B3P LIN28B
Triglycerides 1.67 1 0 0.0 0.00 1.0e+00 AF131215.2
Type 2 Diabetes (T2D) 5.31 1 1 3.0 0.00 1.0e+00 IGKV2OR2-8
Blood Eosinophil Count 1.68 2 1 3.0 0.00 1.0e+00 GBE1 PLEKHM1
Blood Platelet Count 1.51 5 5 15.2 -0.11 8.5e-01 AREL1 C1QTNF4 IGKV2OR2-8 MED19 UBXN2A
Blood Red Count 3.91 5 2 6.1 -0.71 1.8e-01 ATF4 C1QTNF4 MED19 PLEKHM1 UBXN2A
Blood White Count 2.29 5 3 9.1 -0.36 5.5e-01 C1QTNF4 KLHL29 LIN28B PLEKHM1 UBXN2A
Heel T-Score 1.70 4 2 6.1 0.13 8.7e-01 AREL1 C1QTNF4 LIN28B PLEKHM1
BMI 2.57 4 2 6.1 0.68 3.2e-01 ANKK1 APBB3 C1QTNF4 GBE1
Height 2.87 6 6 18.2 0.81 5.0e-02 AREL1 C1QTNF4 KLHL29 LIN28B PLEKHM1 UBXN2A
Waist Hip Ratio (WHR) 2.26 4 1 3.0 -1.00 2.2e-03 AREL1 NCAM1 PLEKHM1 UBXN2A
Systolic Blood Pressure 4.52 5 4 12.1 -0.45 4.5e-01 APBB3 AREL1 C1QTNF4 MED19 PLEKHM1
Smoking Status 1.90 2 0 0.0 0.00 1.0e+00 KLHL29 PLEKHM1
Cardiovascular Disease 1.37 1 0 0.0 0.00 1.0e+00 ANKK1
Hypothyroidism (self reported) 1.85 1 0 0.0 0.00 1.0e+00 C1QTNF4
Respiratory disease 1.55 1 0 0.0 0.00 1.0e+00 APBB3
Type 2 Diabetes (T2D) 1.10 1 0 0.0 0.00 1.0e+00 C1QTNF4
Lung FEV1/FVC ratio 1.20 2 1 3.0 0.00 1.0e+00 AREL1 PLEKHM1
Lung FVC 3.98 3 2 6.1 0.00 1.0e+00 LIN28B PLEKHM1 UBXN2A
Neuroticism 13.29 12 8 24.2 -0.96 7.4e-07 ANKK1 APBB3 AREL1 ATF4 C1QTNF4 GBE1 LIN28B LINGO1 MED19 NCAM1 PLEKHM1 UBXN2A
Chronotype (morning person) 1.97 1 0 0.0 0.00 1.0e+00 UBXN2A
Hair Pigment 0.15 1 0 0.0 0.00 1.0e+00 IGKV2OR2-8
Tanning 0.39 3 0 0.0 0.00 1.0e+00 APBB3 AREL1 C1QTNF4
Hand grip strength (left) 5.13 7 3 9.1 -0.47 2.9e-01 AREL1 C1QTNF4 GBE1 LIN28B LINGO1 PLEKHM1 UBXN2A
Number of treatments/medications taken 3.25 2 1 3.0 0.00 1.0e+00 AREL1 LIN28B
Sensitivity / hurt feelings 9.89 6 2 6.1 0.94 5.8e-03 AF131215.2 ANKK1 FAM86B3P MED19 NCAM1 PLEKHM1
Frequency of depressed mood in last 2 weeks 8.92 7 0 0.0 1.00 7.0e-07 ANKK1 C1QTNF4 FAM86B3P KLHL29 NCAM1 PLEKHM1 UBXN2A
Hearing difficulty/problems: Yes 1.95 1 0 0.0 0.00 1.0e+00 LIN28B
Relative age of first facial hair 5.99 2 2 6.1 0.00 1.0e+00 LIN28B PLEKHM1
Systolic blood pressure, automated reading 4.68 6 5 15.2 -0.56 2.5e-01 AF131215.2 AREL1 C1QTNF4 FAM86B3P MED19 PLEKHM1
Vitamin and mineral supplements 1.57 1 0 0.0 0.00 1.0e+00 PLEKHM1
Medication: Metformin 2.11 1 1 3.0 0.00 1.0e+00 C1QTNF4
Impedance of leg (right) 3.71 7 4 12.1 0.58 1.7e-01 AF131215.2 AREL1 C1QTNF4 FAM86B3P LIN28B PLEKHM1 UBXN2A
Leg fat-free mass (left) 1.90 4 3 9.1 -0.99 5.3e-03 AF131215.2 FAM86B3P LIN28B UBXN2A
Trunk fat percentage 4.44 6 4 12.1 -0.38 4.6e-01 ANKK1 AREL1 C1QTNF4 GBE1 LIN28B PLEKHM1
Hand grip strength (right) 3.63 5 2 6.1 -0.45 4.4e-01 AREL1 C1QTNF4 LIN28B LINGO1 PLEKHM1
Current tobacco smoking 3.03 1 0 0.0 0.00 1.0e+00 UBXN2A
Fed-up feelings 10.66 10 5 15.2 0.97 2.1e-06 AF131215.2 AREL1 C1QTNF4 FAM86B3P GBE1 LINGO1 MED19 NCAM1 PLEKHM1 UBXN2A
Frequency of unenthusiasm / disinterest in last 2 weeks 6.64 5 0 0.0 1.00 4.4e-05 ANKK1 KLHL29 MED19 NCAM1 UBXN2A
Relative age voice broke 5.93 2 2 6.1 0.00 1.0e+00 LIN28B PLEKHM1
Taking other prescription medications 3.36 1 1 3.0 0.00 1.0e+00 AREL1
Age when periods started (menarche) 10.76 3 1 3.0 0.00 1.0e+00 C1QTNF4 LIN28B PLEKHM1
Heel bone mineral density (BMD) T-score, automated (left) 5.31 4 2 6.1 -0.74 2.6e-01 AF131215.2 FAM86B3P LIN28B PLEKHM1
High blood pressure 3.19 4 2 6.1 -0.66 3.4e-01 AF131215.2 C1QTNF4 FAM86B3P PLEKHM1
Medication: Levothyroxine sodium 2.60 1 1 3.0 0.00 1.0e+00 FAM86B3P
Sitting height 3.59 5 4 12.1 -0.72 1.7e-01 C1QTNF4 FAM86B3P KLHL29 PLEKHM1 UBXN2A
Body mass index (BMI) 3.98 5 3 9.1 -0.72 1.7e-01 AF131215.2 ANKK1 C1QTNF4 FAM86B3P GBE1
Impedance of leg (left) 3.87 6 4 12.1 0.59 2.2e-01 AF131215.2 AREL1 FAM86B3P LIN28B PLEKHM1 UBXN2A
Leg predicted mass (left) 1.91 4 3 9.1 -0.99 5.7e-03 AF131215.2 FAM86B3P LIN28B UBXN2A
Trunk fat mass 3.37 8 1 3.0 -0.51 2.0e-01 AF131215.2 ANKK1 AREL1 C1QTNF4 FAM86B3P GBE1 LIN28B PLEKHM1
Waist circumference 2.68 3 1 3.0 0.00 1.0e+00 ANKK1 C1QTNF4 GBE1
Past tobacco smoking 2.02 1 0 0.0 0.00 1.0e+00 PLEKHM1
Alcohol usually taken with meals 2.72 1 0 0.0 0.00 1.0e+00 MED19
Nervous feelings 9.25 7 4 12.1 0.97 3.1e-04 AF131215.2 ANKK1 AREL1 C1QTNF4 FAM86B3P LINGO1 PLEKHM1
Frequency of tenseness / restlessness in last 2 weeks 6.55 4 1 3.0 0.98 2.5e-02 ANKK1 C1QTNF4 KLHL29 PLEKHM1
Hearing difficulty/problems with background noise 3.94 2 0 0.0 0.00 1.0e+00 LIN28B PLEKHM1
Hair/balding pattern: Pattern 2 2.19 1 1 3.0 0.00 1.0e+00 PLEKHM1
Forced vital capacity (FVC) 3.44 4 1 3.0 -0.89 1.1e-01 C1QTNF4 KLHL29 PLEKHM1 UBXN2A
Heel bone mineral density (BMD) T-score, automated (right) 5.69 4 2 6.1 -0.78 2.2e-01 AF131215.2 FAM86B3P LIN28B PLEKHM1
Ever unenthusiastic/disinterested for a whole week 3.14 1 0 0.0 0.00 1.0e+00 PLEKHM1
Mouth/teeth dental problems 2.19 1 0 0.0 0.00 1.0e+00 PLEKHM1
Fluid intelligence score 2.32 1 0 0.0 0.00 1.0e+00 PLEKHM1
Neuroticism score 18.18 13 10 30.3 0.96 1.6e-07 AF131215.2 ANKK1 APBB3 AREL1 ATF4 C1QTNF4 FAM86B3P GBE1 LINGO1 MED19 NCAM1 PLEKHM1 UBXN2A
Weight 2.01 6 3 9.1 -0.70 1.2e-01 AF131215.2 ANKK1 C1QTNF4 FAM86B3P LIN28B UBXN2A
Impedance of arm (right) 4.55 6 4 12.1 0.40 4.4e-01 AF131215.2 FAM86B3P LIN28B MED19 PLEKHM1 UBXN2A
Arm fat percentage (right) 4.49 7 2 6.1 -0.26 5.8e-01 AF131215.2 ANKK1 AREL1 C1QTNF4 FAM86B3P GBE1 MED19
Trunk fat-free mass 2.21 6 1 3.0 -0.97 1.8e-03 AF131215.2 AREL1 FAM86B3P KLHL29 LIN28B UBXN2A
Hip circumference 2.26 5 1 3.0 -0.68 2.1e-01 AF131215.2 ANKK1 C1QTNF4 FAM86B3P GBE1
Time employed in main current job 2.07 1 0 0.0 0.00 1.0e+00 PLEKHM1
Father's age at death 2.44 1 0 0.0 0.00 1.0e+00 AF131215.2
Worrier / anxious feelings 11.42 7 4 12.1 0.94 1.8e-03 AF131215.2 AREL1 FAM86B3P IGKV2OR2-8 LINGO1 MED19 PLEKHM1
Frequency of tiredness / lethargy in last 2 weeks 5.42 4 0 0.0 1.00 2.5e-03 ANKK1 KLHL29 MED19 UBXN2A
Hair/balding pattern: Pattern 3 3.94 1 1 3.0 0.00 1.0e+00 PLEKHM1
Number of live births 1.45 1 0 0.0 0.00 1.0e+00 PLEKHM1
Forced expiratory volume in 1-second (FEV1) 4.12 6 1 3.0 -0.35 5.0e-01 AF131215.2 C1QTNF4 FAM86B3P KLHL29 PLEKHM1 UBXN2A
Qualifications: A levels/AS levels or equivalent 2.31 1 0 0.0 0.00 1.0e+00 PLEKHM1
Mouth/teeth dental problems: Dentures 2.14 2 0 0.0 0.00 1.0e+00 AF131215.2 FAM86B3P
Asthma 1.51 1 0 0.0 0.00 1.0e+00 APBB3
Medication: Ibuprofen (e.g. Nurofen) 3.31 2 0 0.0 0.00 1.0e+00 PLEKHM1 UBXN2A
Depression (self-reported) 3.02 1 0 0.0 0.00 1.0e+00 LIN28B
Forced expiratory volume in 1-second (FEV1), Best measure 3.87 6 1 3.0 -0.34 5.1e-01 AF131215.2 C1QTNF4 FAM86B3P KLHL29 PLEKHM1 UBXN2A
Impedance of arm (left) 4.43 6 5 15.2 0.38 4.6e-01 AF131215.2 FAM86B3P LIN28B MED19 PLEKHM1 UBXN2A
Arm fat mass (right) 3.53 5 3 9.1 -0.66 2.3e-01 AF131215.2 ANKK1 C1QTNF4 FAM86B3P GBE1
Trunk predicted mass 2.23 6 1 3.0 -0.97 1.6e-03 AF131215.2 AREL1 FAM86B3P KLHL29 LIN28B UBXN2A
Standing height 3.07 7 4 12.1 -0.43 3.3e-01 AF131215.2 C1QTNF4 FAM86B3P KLHL29 LIN28B PLEKHM1 UBXN2A
Tense / 'highly strung' 6.64 5 2 6.1 0.98 4.1e-03 AF131215.2 ANKK1 AREL1 FAM86B3P PLEKHM1
Seen doctor (GP) for nerves, anxiety, tension or depression 4.89 2 0 0.0 0.00 1.0e+00 ANKK1 AREL1
Hair/balding pattern: Pattern 4 6.21 2 1 3.0 0.00 1.0e+00 APBB3 PLEKHM1
Peak expiratory flow (PEF) 4.06 4 1 3.0 -0.15 8.5e-01 AF131215.2 FAM86B3P PLEKHM1 UBXN2A
Medication: Paracetamol 4.65 3 1 3.0 0.00 1.0e+00 MED19 PLEKHM1 UBXN2A
Headache pain in last month 4.65 2 1 3.0 0.00 1.0e+00 MED19 PLEKHM1
Hypothyroidism/myxoedema (self-reported) 3.09 2 1 3.0 0.00 1.0e+00 AF131215.2 FAM86B3P
Birth weight 1.87 1 0 0.0 0.00 1.0e+00 UBXN2A
Forced vital capacity (FVC), Best measure 3.44 4 2 6.1 -0.86 1.4e-01 C1QTNF4 KLHL29 PLEKHM1 UBXN2A
Body fat percentage 4.33 6 3 9.1 -0.22 6.7e-01 ANKK1 AREL1 C1QTNF4 FAM86B3P GBE1 PLEKHM1
Leg fat percentage (right) 4.02 8 2 6.1 0.04 9.2e-01 AF131215.2 ANKK1 AREL1 C1QTNF4 FAM86B3P GBE1 KLHL29 UBXN2A
Arm fat-free mass (right) 1.84 3 2 6.1 0.00 1.0e+00 AF131215.2 FAM86B3P UBXN2A
Comparative body size at age 10 3.92 4 4 12.1 -0.61 3.9e-01 AF131215.2 C1QTNF4 FAM86B3P LIN28B
Worry too long after embarrassment 9.36 9 3 9.1 0.98 1.9e-06 AF131215.2 ANKK1 APBB3 ATF4 FAM86B3P LINGO1 MED19 NCAM1 PLEKHM1
Age at first live birth 2.39 2 0 0.0 0.00 1.0e+00 AF131215.2 PLEKHM1
Qualifications: College or University degree 2.00 1 1 3.0 0.00 1.0e+00 PLEKHM1
Emphysema/chronic bronchitis 2.58 1 0 0.0 0.00 1.0e+00 FAM86B3P
Medication for pain relief, constipation, heartburn 3.60 3 1 3.0 0.00 1.0e+00 AREL1 PLEKHM1 UBXN2A
Medication: Blood pressure 2.07 1 0 0.0 0.00 1.0e+00 AF131215.2
Medication: Ibuprofen 2.65 1 0 0.0 0.00 1.0e+00 PLEKHM1
Whole body fat mass 3.27 5 1 3.0 -0.64 2.5e-01 AF131215.2 ANKK1 C1QTNF4 FAM86B3P GBE1
Leg fat mass (right) 3.25 5 3 9.1 -0.67 2.2e-01 AF131215.2 ANKK1 C1QTNF4 FAM86B3P GBE1
Arm predicted mass (right) 1.84 3 3 9.1 0.00 1.0e+00 AF131215.2 FAM86B3P UBXN2A
Alcohol intake frequency. 4.09 3 2 6.1 0.00 1.0e+00 C1QTNF4 PLEKHM1 UBXN2A
Comparative height size at age 10 1.38 3 0 0.0 0.00 1.0e+00 KLHL29 PLEKHM1 UBXN2A
Suffer from 'nerves' 8.69 7 3 9.1 0.97 2.4e-04 AF131215.2 ANKK1 AREL1 C1QTNF4 FAM86B3P LINGO1 PLEKHM1
Overall health rating 2.77 3 0 0.0 0.00 1.0e+00 AF131215.2 ANKK1 NCAM1
Had major operations 1.99 1 0 0.0 0.00 1.0e+00 IGKV2OR2-8
Age at last live birth 2.34 1 0 0.0 0.00 1.0e+00 AF131215.2
Hypertension (Self-reported) 3.06 4 2 6.1 -0.66 3.4e-01 AF131215.2 C1QTNF4 FAM86B3P PLEKHM1
Forced expiratory volume in 1-second (FEV1), predicted 1.96 1 1 3.0 0.00 1.0e+00 LIN28B
Whole body fat-free mass 1.97 4 2 6.1 -1.00 4.3e-03 AF131215.2 FAM86B3P LIN28B UBXN2A
Leg fat-free mass (right) 1.89 4 3 9.1 -1.00 4.5e-03 AF131215.2 FAM86B3P LIN28B UBXN2A
Arm fat percentage (left) 4.70 7 3 9.1 -0.29 5.3e-01 AF131215.2 ANKK1 AREL1 C1QTNF4 FAM86B3P GBE1 MED19
Average weekly red wine intake 3.06 1 0 0.0 0.00 1.0e+00 MED19
Handedness (chirality/laterality): Left-handed 2.84 1 1 3.0 0.00 1.0e+00 PLEKHM1
Mood swings 9.92 8 4 12.1 0.99 4.9e-06 AF131215.2 ANKK1 AREL1 C1QTNF4 FAM86B3P KLHL29 NCAM1 PLEKHM1
Loneliness, isolation 6.99 3 1 3.0 0.00 1.0e+00 C1QTNF4 GBE1 PLEKHM1
Long-standing illness, disability or infirmity 2.28 1 0 0.0 0.00 1.0e+00 LIN28B
Diabetes diagnosed by doctor 1.15 1 0 0.0 0.00 1.0e+00 C1QTNF4
Mouth/teeth dental problems: Mouth ulcers 2.67 1 1 3.0 0.00 1.0e+00 PLEKHM1
Medication for cholesterol 2.33 1 0 0.0 0.00 1.0e+00 PLEKHM1
Asthma (self-reported) 1.55 1 0 0.0 0.00 1.0e+00 APBB3
Smoking status: Current 2.98 1 0 0.0 0.00 1.0e+00 UBXN2A
Forced expiratory volume in 1-second (FEV1), predicted percentage 3.01 2 1 3.0 0.00 1.0e+00 AF131215.2 PLEKHM1
Whole body water mass 1.98 4 2 6.1 -0.99 5.1e-03 AF131215.2 FAM86B3P LIN28B UBXN2A
Leg predicted mass (right) 1.89 4 3 9.1 -1.00 4.6e-03 AF131215.2 FAM86B3P LIN28B UBXN2A
Arm fat mass (left) 3.57 5 3 9.1 -0.67 2.1e-01 AF131215.2 ANKK1 C1QTNF4 FAM86B3P GBE1
Number of self-reported non-cancer illnesses 1.76 1 0 0.0 0.00 1.0e+00 AREL1
Miserableness 11.64 8 7 21.2 0.99 2.5e-06 AF131215.2 ANKK1 C1QTNF4 FAM86B3P LINGO1 NCAM1 PLEKHM1 UBXN2A
Medication: Blood pressure 3.52 3 2 6.1 0.00 1.0e+00 AF131215.2 FAM86B3P PLEKHM1
Medication: Bendroflumethiazide 3.09 2 0 0.0 0.00 1.0e+00 AF131215.2 FAM86B3P
Medication: Paracetamol 4.06 2 1 3.0 0.00 1.0e+00 PLEKHM1 UBXN2A
Alcohol drinker status: Never 1.93 1 0 0.0 0.00 1.0e+00 C1QTNF4
Basal metabolic rate 1.80 4 2 6.1 -1.00 2.3e-03 AF131215.2 FAM86B3P LIN28B UBXN2A
Leg fat percentage (left) 4.16 7 2 6.1 -0.07 8.7e-01 AF131215.2 ANKK1 AREL1 C1QTNF4 FAM86B3P GBE1 KLHL29
Arm fat-free mass (left) 1.82 3 2 6.1 0.00 1.0e+00 AF131215.2 FAM86B3P UBXN2A
Number of operations (self-reported) 3.02 1 0 0.0 0.00 1.0e+00 LIN28B
Average weekly beer plus cider intake 3.06 1 0 0.0 0.00 1.0e+00 FAM86B3P
Irritability 8.12 5 3 9.1 0.97 6.7e-03 AF131215.2 ANKK1 AREL1 FAM86B3P PLEKHM1
Risk taking 2.81 1 0 0.0 0.00 1.0e+00 AF131215.2
Fractured/broken bones in last 5 years 1.71 1 0 0.0 0.00 1.0e+00 PLEKHM1
Diastolic blood pressure, automated reading 3.31 3 2 6.1 0.00 1.0e+00 AF131215.2 C1QTNF4 FAM86B3P
Ever depressed for a whole week 2.52 1 0 0.0 0.00 1.0e+00 PLEKHM1
Vascular/heart problems diagnosed by doctor 2.85 2 1 3.0 0.00 1.0e+00 AF131215.2 FAM86B3P
Pain experienced in last month 2.06 1 0 0.0 0.00 1.0e+00 PLEKHM1
Alcohol drinker status: Previous 2.35 1 0 0.0 0.00 1.0e+00 ATF4
Impedance of whole body 4.40 6 5 15.2 0.39 4.5e-01 AF131215.2 AREL1 FAM86B3P LIN28B PLEKHM1 UBXN2A
Leg fat mass (left) 3.28 5 3 9.1 -0.67 2.1e-01 AF131215.2 ANKK1 C1QTNF4 FAM86B3P GBE1
Arm predicted mass (left) 1.84 3 2 6.1 0.00 1.0e+00 AF131215.2 FAM86B3P UBXN2A

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 3 0.0859 1.47
GTEx Adipose Visceral Omentum 4 0.1965 1.56
GTEx Adrenal Gland 1 0.0686 1.57
GTEx Artery Aorta 4 0.1344 1.51
GTEx Artery Coronary 4 0.3381 1.70
GTEx Artery Tibial 3 0.0798 1.50
GTEx Brain Caudate basal ganglia 2 0.2174 1.67
GTEx Brain Cerebellar Hemisphere 3 0.2015 1.57
GTEx Brain Cerebellum 3 0.1514 1.54
GTEx Brain Cortex 2 0.1932 1.70
GTEx Brain Frontal Cortex BA9 4 0.4329 1.60
GTEx Brain Hippocampus 1 0.1908 1.71
GTEx Brain Hypothalamus 3 0.5085 1.54
GTEx Brain Nucleus accumbens basal ganglia 2 0.2312 1.56
GTEx Brain Putamen basal ganglia 2 0.3205 1.60
GTEx Breast Mammary Tissue 4 0.2026 1.55
GTEx Breast Mammary Tissue (Male) 2 0.1676 1.44
GTEx Breast Mammary Tissue (Female) 4 0.2433 1.55
GTEx Cells EBV-transformed lymphocytes 5 0.3514 1.69
GTEx Cells Transformed fibroblasts 4 0.0953 1.50
GTEx Colon Sigmoid 4 0.2736 1.58
GTEx Colon Transverse 4 0.1938 1.59
GTEx Esophagus Gastroesophageal Junction 4 0.2768 1.58
GTEx Esophagus Mucosa 4 0.1205 1.52
GTEx Esophagus Muscularis 3 0.0928 1.60
GTEx Heart Atrial Appendage 5 0.3167 1.66
GTEx Heart Left Ventricle 4 0.2614 1.60
GTEx Liver 2 0.2789 1.65
GTEx Lung 2 0.0696 1.54
GTEx Muscle Skeletal 5 0.1730 1.55
GTEx Nerve Tibial 2 0.0463 1.49
GTEx Ovary 1 0.1101 1.58
GTEx Pancreas 3 0.1838 1.56
GTEx Pituitary 2 0.1794 1.64
GTEx Prostate 4 0.4790 1.59
GTEx Skin Not Sun Exposed Suprapubic 5 0.2033 1.57
GTEx Skin Sun Exposed Lower leg 8 0.2198 1.54
GTEx Small Intestine Terminal Ileum 3 0.6508 1.94
GTEx Spleen 3 0.2126 1.60
GTEx Stomach 2 0.1376 1.57
GTEx Testis 9 0.2853 1.59
GTEx Thyroid 2 0.0500 1.52
GTEx Uterus 5 0.8818 1.85
GTEx Vagina 2 0.3150 1.61
GTEx Whole Blood 3 0.1505 1.47
METSIM Adipose 2 0.0434 1.41
NTR Blood 0 0.0000 1.45
ROSMAP Brain Pre-frontal Cortex 5 0.1139 1.62
YFS Blood 3 0.0650 1.41
CommonMind Brain Pre-frontal Cortex 3 0.0558 1.50
TCGA Breast Tumor 0 0.0000 1.42
TCGA Breast Normal 1 0.0238 1.41
TCGA Ovarian Tumor 2 0.0684 1.52
TCGA Prostate Tumor 1 0.0289 1.45